National Donor Deferral Registry (NDDR) Helps Ensure That Deferred Donors Cannot Donate Their Plasma Again
The National Donor Deferral Registry (NDDR) is a database of permanently deferred plasma donors in North America. It is one of many voluntary, self-regulating initiatives taken by the source plasma collection industry and is an important component of the industry-driven safety measures taken to help ensure the safety of the final therapies.
All donors who test "reactive" for the viral agents for HIV, HBV and HCV are added to the NDDR and are permanently prohibited from donating source plasma at participating licensed and industry-certified centers in the U.S. and Canada.
The NDDR first was made available to all blood and source plasma facilities in December 1993. Haemonetics, a valued partner of PPTA, is responsible for the administration and customer support services of the NDDR.
All inquires should be directed to the NDDR Customer Support Desk at 1-877-534-3578.
PPTA Comments on the IQWiG Rapid Report on Haemophilia Therapies +
On October 11, 2012, the German Federal Ministry of Health (BMG) commissioned the Institute for Quality and Efficiency in Health Care (IQWiG) to assess the treatment of haemophilia patients through the production of a Health Technology Assessment (HTA) Rapid Report.Read More
New Supplement Addresses Hemolytic Complications of IVIG Infusions +
Plasma Protein Forum Highlights +
The 2015 Plasma Protein Forum concluded June 17 with panels that covered industry challenges, patient voices, benefits of plasma donation, self-sufficiency, and regulatory issues. More than 300 people from across the industry attended the two-day event in Washington, D.C.Read More
PPTA Standards Programs